Cleveland Research initiated coverage of Lam Research (LRCX) with a Neutral rating. The firm’s checks suggest slower than expected revenue recovery due to end demand concerns, new fab construction being on hold, and U.S. CHIPS Act funding delays, the analyst tells investors.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on LRCX:
- Lam Research price target lowered to $87 from $90 at Citi
- Lam Research price target raised to $78 from $76 at Morgan Stanley
- Lam Research issues statement on newly announced export regulations
- Early notable gainers among liquid option names on December 2nd
- U.S. Enacts Toughest Chip Export Controls to Curb China’s AI Ambitions
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
